Michael S. Aberman, SVP Strategy Investor Relation at REGENERON PHARMACEUTICALS INC (REGN), sold 4,500 shares at $525.21 ($2.3M) on 2017-06-22, disclosed to the SEC on 2017-06-23.
Open-market sale of $2.3M REGN by SVP Strategy Investor Relation. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $510.02 | 1,961 | $1.0M | 42.6% |
| 2 | $510.02 | 270 | $138K | 5.9% |
| 3 | $525.21 | 395 | $207K | 8.8% |
| 4 | $526.02 | 100 | $53K | 2.2% |
| 5 | $529.61 | 100 | $53K | 2.3% |
| 6 | $530.66 | 100 |
| $53K |
| 2.3% |
| 7 | $531.51 | 274 | $146K | 6.2% |
| 8 | $532.27 | 200 | $106K | 4.5% |
| 9 | $533.48 | 200 | $107K | 4.5% |
| 10 | $534.51 | 200 | $107K | 4.6% |
| 11 | $536.52 | 400 | $215K | 9.1% |
| 12 | $537.50 | 100 | $54K | 2.3% |
| 13 | $538.30 | 100 | $54K | 2.3% |
| 14 | $541.00 | 100 | $54K | 2.3% |
| Total | $521.31 avg | 4,500 | $2.3M | 100% |
| Filing → |
| REGN | SELL | 2015-02-25 | $1.4M | — | Filing → |
| REGN | SELL | 2015-02-18 | $1.5M | — | Filing → |
| REGN | SELL | 2014-08-19 | $1.3M | — | Filing → |